Exome sequencing identifies a new candidate mutation for susceptibility to diabetes in a family with highly aggregated type 2 diabetes

Molecular Genetics and Metabolism

Volumn 109, Issue 1, 2013, Pages 112-117

  Tanaka, Daisuke ^a   Nagashima, Kazuaki ^a   Sasaki, Mayumi ^a   Funakoshi, Shogo ^a   Kondo, Yasushi ^a   Yasuda, Koichiro ^b   Koizumi, Akio ^a   Inagaki, Nobuya ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Osaka Saiseikai Noe Hospital   (Japan)

Author keywords

EEA1; Exome sequencing; Genetics of type 2 diabetes; Linkage analysis

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADULT; AGED; ARTICLE; CHROMOSOME 12P; CHROMOSOME 4Q; CHROMOSOME 5Q; CLINICAL ARTICLE; DIET THERAPY; DISEASE PREDISPOSITION; EXOME; FAMILY HISTORY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; JAPANESE; LINKAGE ANALYSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

DIABETES MELLITUS, TYPE 2; EXOME; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; HUMANS; MUTATION; PEDIGREE; SEQUENCE ANALYSIS, DNA; VESICULAR TRANSPORT PROTEINS;

EID: 84876074049     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2013.02.010     Document Type: Article

References (26)

1. International Diabetes Federation IDF Diabetes Atlas 2011, 5th ed.
2. Imamura M., Maeda S. Genetics of type 2 diabetes: the GWAS era and future perspectives. Endocr. J. 2011, 58:723-739. (Review).
3. Voight B.F., Scott L.J., Steinthorsdottir V., Morris A.P., Dina C., Welch R.P., Zeggini E., Huth C., Aulchenko Y.S., Thorleifsson G., McCulloch L.J., Ferreira T., Grallert H., Amin N., Wu G., Willer C.J., Raychaudhuri S., McCarroll S.A., Langenberg C., Hofmann O.M., Dupuis J., Qi L., Segrè A.V., van Hoek M., Navarro P., Ardlie K., Balkau B., Benediktsson R., Bennett A.J., Blagieva R., Boerwinkle E., Bonnycastle L.L., Bengtsson Boström K., Bravenboer B., Bumpstead S., Burtt N.P., Charpentier G., Chines P.S., Cornelis M., Couper D.J., Crawford G., Doney A.S., Elliott K.S., Elliott A.L., Erdos M.R., Fox C.S., Franklin C.S., Ganser M., Gieger C., Grarup N., Green T., Griffin S., Groves C.J., Guiducci C., Hadjadj S., Hassanali N., Herder C., Isomaa B., Jackson A.U., Johnson P.R., Jørgensen T., Kao W.H., Klopp N., Kong A., Kraft P., Kuusisto J., Lauritzen T., Li M., Lieverse A., Lindgren C.M., Lyssenko V., Marre M., Meitinger T., Midthjell K., Morken M.A., Narisu N., Nilsson P., Owen K.R., Payne F., Perry J.R., Petersen A.K., Platou C., Proença C., Prokopenko I., Rathmann W., Rayner N.W., Robertson N.R., Rocheleau G., Roden M., Sampson M.J., Saxena R., Shields B.M., Shrader P., Sigurdsson G., Sparsø T., Strassburger K., Stringham H.M., Sun Q., Swift A.J., Thorand B., Tichet J., Tuomi T., van Dam R.M., van Haeften T.W., van Herpt T., van Vliet-Ostaptchouk J.V., Walters G.B., Weedon M.N., Wijmenga C., Witteman J., Bergman R.N., Cauchi S., Collins F.S., Gloyn A.L., Gyllensten U., Hansen T., Hide W.A., Hitman G.A., Hofman A., Hunter D.J., Hveem K., Laakso M., Mohlke K.L., Morris A.D., Palmer C.N., Pramstaller P.P., Rudan I., Sijbrands E., Stein L.D., Tuomilehto J., Uitterlinden A., Walker M., Wareham N.J., Watanabe R.M., Abecasis G.R., Boehm B.O., Campbell H., Daly M.J., Hattersley A.T., Hu F.B., Meigs J.B., Pankow J.S., Pedersen O., Wichmann H.E., Barroso I., Florez J.C., Frayling T.M., Groop L., Sladek R., Thorsteinsdottir U., Wilson J.F., Illig T., Froguel P., van Duijn C.M., Stefansson K., Altshuler D., Boehnke M., McCarthy M.I., M.investigators, G. Consortium Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 2010, 42:579-589.
4. Miyake K., Yang W., Hara K., Yasuda K., Horikawa Y., Osawa H., Furuta H., Ng M.C., Hirota Y., Mori H., Ido K., Yamagata K., Hinokio Y., Oka Y., Iwasaki N., Iwamoto Y., Yamada Y., Seino Y., Maegawa H., Kashiwagi A., Wang H.Y., Tanahashi T., Nakamura N., Takeda J., Maeda E., Yamamoto K., Tokunaga K., Ma R.C., So W.Y., Chan J.C., Kamatani N., Makino H., Nanjo K., Kadowaki T., Kasuga M. Construction of a prediction model for type 2 diabetes mellitus in the Japanese population based on 11 genes with strong evidence of the association. J. Hum. Genet. 2009, 54:236-241.
5. Bodmer W., Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat. Genet. 2008, 40:695-701.
6. Liu W., Morito D., Takashima S., Mineharu Y., Kobayashi H., Hitomi T., Hashikata H., Matsuura N., Yamazaki S., Toyoda A., Kikuta K., Takagi Y., Harada K.H., Fujiyama A., Herzig R., Krischek B., Zou L., Kim J.E., Kitakaze M., Miyamoto S., Nagata K., Hashimoto N., Koizumi A. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS One 2011, 6:e22542.
7. Yamagata K. Regulation of pancreatic beta-cell function by the HNF transcription network: lessons from maturity-onset diabetes of the young (MODY). Endocr. J. 2003, 50:491-499.
8. Yorifuji T., Fujimaru R., Hosokawa Y., Tamagawa N., Shiozaki M., Aizu K., Jinno K., Maruo Y., Nagasaka H., Tajima T., Kobayashi K., Urakami T. Comprehensive molecular analysis of Japanese patients with pediatric-onset MODY-type diabetes mellitus. Pediatr. Diabetes 2012, 13:26-32.
9. Bamshad M.J., Ng S.B., Bigham A.W., Tabor H.K., Emond M.J., Nickerson D.A., Shendure J. Exome sequencing as a tool for Mendelian disease gene discovery. Nat. Rev. Genet. 2011, 12:745-755.
10. Saudek C.D., Herman W.H., Sacks D.B., Bergenstal R.M., Edelman D., Davidson M.B. A new look at screening and diagnosing diabetes mellitus. J. Clin. Endocrinol. Metab. 2008, 93:2447-2453.
11. Ellard S., Bellanné-Chantelot C., Hattersley A.T., E.M.G.Q.N.E.M. group Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia 2008, 51:546-553.
12. Kruglyak L., Daly M.J., Reeve-Daly M.P., Lander E.S. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am. J. Hum. Genet. 1996, 58:1347-1363.
13. Zhu Q., Yamagata K., Miura A., Shihara N., Horikawa Y., Takeda J., Miyagawa J., Matsuzawa Y. T130I mutation in HNF-4alpha gene is a loss-of-function mutation in hepatocytes and is associated with late-onset Type 2 diabetes mellitus in Japanese subjects. Diabetologia 2003, 46:567-573.
14. Bonnefond A., Durand E., Sand O., De Graeve F., Gallina S., Busiah K., Lobbens S., Simon A., Bellanné-Chantelot C., Létourneau L., Scharfmann R., Delplanque J., Sladek R., Polak M., Vaxillaire M., Froguel P. Molecular diagnosis of neonatal diabetes mellitus using next-generation sequencing of the whole exome. PLoS One 2010, 5:e13630.
15. Johansson S., Irgens H., Chudasama K.K., Molnes J., Aerts J., Roque F.S., Jonassen I., Levy S., Lima K., Knappskog P.M., Bell G.I., Molven A., Njølstad P.R. Exome sequencing and genetic testing for MODY. PLoS One 2012, 7:e38050.
16. Bonnefond A., Philippe J., Durand E., Dechaume A., Huyvaert M., Montagne L., Marre M., Balkau B., Fajardy I., Vambergue A., Vatin V., Delplanque J., Le Guilcher D., De Graeve F., Lecoeur C., Sand O., Vaxillaire M., Froguel P. Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene. PLoS One 2012, 7:e37423.
17. Lieber D.S., Vafai S.B., Horton L.C., Slate N.G., Liu S., Borowsky M.L., Calvo S.E., Schmahmann J.D., Mootha V.K. Atypical case of Wolfram syndrome revealed through targeted exome sequencing in a patient with suspected mitochondrial disease. BMC Med. Genet. 2012, 13:3.
18. Mu F.T., Callaghan J.M., Steele-Mortimer O., Stenmark H., Parton R.G., Campbell P.L., McCluskey J., Yeo J.P., Tock E.P., Toh B.H. EEA1, an early endosome-associated protein. EEA1 is a conserved alpha-helical peripheral membrane protein flanked by cysteine "fingers" and contains a calmodulin-binding IQ motif. J. Biol. Chem. 1995, 270:13503-13511.
19. Stenmark H., Aasland R., Toh B.H., D'Arrigo A. Endosomal localization of the autoantigen EEA1 is mediated by a zinc-binding FYVE finger. J. Biol. Chem. 1996, 271:24048-24054.
20. Simonsen A., Lippé R., Christoforidis S., Gaullier J.M., Brech A., Callaghan J., Toh B.H., Murphy C., Zerial M., Stenmark H. EEA1 links PI(3)K function to Rab5 regulation of endosome fusion. Nature 1998, 394:494-498.
21. Dumas J.J., Merithew E., Sudharshan E., Rajamani D., Hayes S., Lawe D., Corvera S., Lambright D.G. Multivalent endosome targeting by homodimeric EEA1. Mol. Cell 2001, 8:947-958.
22. Cheng R., Qiu J., Zhou X.Y., Chen X.H., Zhu C., Qin D.N., Wang J.W., Ni Y.H., Ji C.B., Guo X.R. Knockdown of STEAP4 inhibits insulin-stimulated glucose transport and GLUT4 translocation via attenuated phosphorylation of Akt, independent of the effects of EEA1. Mol. Med. Rep. 2011, 4:519-523.
23. Fujita P.A., Rhead B., Zweig A.S., Hinrichs A.S., Karolchik D., Cline M.S., Goldman M., Barber G.P., Clawson H., Coelho A., Diekhans M., Dreszer T.R., Giardine B.M., Harte R.A., Hillman-Jackson J., Hsu F., Kirkup V., Kuhn R.M., Learned K., Li C.H., Meyer L.R., Pohl A., Raney B.J., Rosenbloom K.R., Smith K.E., Haussler D., Kent W.J. The UCSC genome browser database: update 2011. Nucleic Acids Res. 2011, 39:D876-D882.
24. Karakoc E., Alkan C., O'Roak B.J., Dennis M.Y., Vives L., Mark K., Rieder M.J., Nickerson D.A., Eichler E.E. Detection of structural variants and indels within exome data. Nat. Methods 2012, 9:176-178.
25. Adzhubei I.A., Schmidt S., Peshkin L., Ramensky V.E., Gerasimova A., Bork P., Kondrashov A.S., Sunyaev S.R. A method and server for predicting damaging missense mutations. Nat. Methods 2010, 7:248-249.
26. Wang P., Sun B., Hao D., Zhang X., Shi T., Ma D. Human TMEM174 that is highly expressed in kidney tissue activates AP-1 and promotes cell proliferation. Biochem. Biophys. Res. Commun. 2010, 394:993-999.